Brief: FDA Approves First Generic Of Drug Used To Treat Severe Hypoglycemia
Dec 28 (Reuters) - FDA:
* FDA - APPROVES FIRST GENERIC OF DRUG USED TO TREAT SEVERE
HYPOGLYCEMIA
* FDA - FDA GRANTED APPROVAL OF THIS GENERIC GLUCAGON FOR
INJECTION TO AMPHASTAR PHARMACEUTICALS, INC. OF RANCHO
CUCAMONGA, CALIF
Source text: [https://bit.ly/3aPuil9]
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amphastar Pharmaceuticals,
See all newsU.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla
Amphastar Q1 revenue and adjusted EPS miss estimates
Brief: Amphastar Pharmaceuticals Q1 EPS USD 0.14
Brief: Amphastar Pharmaceuticals Inc - Authorizes $50 Million Increase To Share Buyback Program On March 12, 2026 - SEC Filing
Brief: Amphastar Pharmaceuticals- Nanjing Pharmaceuticals Enters Supply Agreement With Nanjing Letop Biotechnology On March 3 - SEC Filing